Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stathmin 2 (STMN2)
- Target
- STMN2
- Molecular classification
- Phosphoprotein, Microtubule regulator
01
Overview
Stathmin 2 (STMN2), also known as superior cervical ganglion 10 protein (SCG10), is a member of the stathmin family of phosphoproteins that regulates microtubule dynamics. It plays a crucial role in neuronal growth, repair, and signal transduction. Decreased STMN2 expression is associated with neurodegenerative diseases, particularly ALS, making it a potential biomarker and therapeutic target. Its function is modulated by phosphorylation, leading to either stabilization or destabilization of microtubules.
- Other names
- SCG10Superior cervical ganglion protein 10
02
Mechanism of action
Phosphorylation-dependent microtubule stabilization/destabilization
03
Biological functions
Microtubule regulationNeuronal growthAxonal stabilityNeural repairNeurite outgrowth
04
Disease associations
Amyotrophic lateral sclerosis (ALS)Down's syndromeAlzheimer's diseaseTrichorhinophalangeal Syndrome Type IICreutzfeldt-Jakob DiseaseNeurodegenerative disease
05
Safety considerations
Potential therapeutic challenges due to its complex role in microtubule dynamics
06
Biomarkers
Decreased STMN2 expression in ALSTDP-43 pathology related to STMN2 levels
Beyond the preview
Go deeper on Stathmin 2 (STMN2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Stathmin 2 (STMN2).